A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for Focal Upper Limb Spasticity Due to Upper Motor Neuron Syndrome.
Latest Information Update: 03 Mar 2015
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Adverse reactions
- Sponsors Allergan
Most Recent Events
- 26 May 2011 New trial record